Maexeni 20

Ethinylestradiol and Levonorgestrel, the active ingredients in Maexeni 20, are a combined oral contraceptive presented as a tablet for oral use. They prevent pregnancy in women of reproductive age.

GNH USA supplies Maexeni 20 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maexeni 20, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

Contraception: provides effective prevention of ovulation and pregnancy. Menstrual cycle regulation: helps achieve more regular menstrual bleeding patterns. Treatment of dysmenorrhea: can reduce painful menstrual cramps.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Spotting between periods: irregular light bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to lung vessels. - Severe allergic reaction: anaphylaxis with rash, swelling, or breathing difficulty.

Before starting Maexeni 20, consider the following precautions: - Smoking: avoid use if over 35 years and a smoker due to increased thrombotic risk. - Cardiovascular disease: assess risk of heart attack or stroke before prescribing. - History of thromboembolism: contraindicated in patients with prior clotting events. - Liver disease: monitor hepatic function as metabolism occurs in the liver. - Migraine with aura: avoid as it may elevate stroke risk. - Store at ambient temperature: keep in the original pack, protect from moisture.

Maexeni 20 may interact with several medicines. Review patient medication lists carefully.

Major Interactions (Avoid): - Rifampin: strong CYP3A4 inducer that reduces contraceptive efficacy. - Phenytoin: enzyme inducer leading to decreased hormone levels. - Carbamazepine: lowers plasma concentrations of both hormones.

Moderate Interactions (Monitor Closely): - St. John’s wort: herbal inducer that may diminish effectiveness. - Ketoconazole: antifungal that can increase hormone levels. - Ritonavir: antiretroviral that may alter hormone metabolism. - Ciprofloxacin: fluoroquinolone antibiotic with potential modest effect.